Notice of AGM and 2021 Report and Accounts

RNS Number : 1227N

Intelligent Ultrasound Group PLC

30 May 2022

 

Intelligent Ultrasound Group plc

("Intelligent Ultrasound" or the "Group" or the "Company")

Notice of Annual General Meeting and 2021 Report and Accounts

Intelligent Ultrasound Group plc (AIM: IUG), the 'classroom to clinic' ultrasound company, specialising in artificial intelligence (AI) software and simulation, announces that the following documents have been published on the Company's website www.intelligentultrasound.com/reports-presentations/ .

· 2021 Report and Accounts;

· Notice of 2022 Annual General Meeting (AGM Notice); and

· Form of Proxy

The Company has historically adopted a higher standard of governance which recommends all Directors offer themselves for re-election annually. To ensure that this higher standard of governance is not in conflict with the Articles of Association, the Company is proposing a resolution at this year's AGM to amend the Articles to require all Directors to retire prior to offering themselves for re-election annually.

At this year's AGM, all Directors will therefore retire. The biographical details of the Directors who are offering themselves for re-election at the meeting are set out in the annual report and accounts and appear on the Company's website.

Professor Nazar Amso and David Baynes, who have been Directors within the Group respectively for 17 and 12 years, will be retiring from the Board and not standing for re-election. The Board would like to take this opportunity to thank each of Professor Nazar Amso, the founder of the original Company, and David Baynes, the representative of the original major investor, for their significant contribution to the Company over the past years.

Printed copies of the 2021 Report and Accounts and the 2022 AGM Notice have been posted to those shareholders that have requested hard copies.

The 2022 AGM will be held at the Memery Crystal's offices at 165 Fleet Street, London EC4A 2DY at 11:00am on 22 June 2022.

For further information, please contact:

Intelligent Ultrasound Group plc			www.  intelligentultrasound.com
Stuart Gall, CEO			Tel: [phone]
Helen Jones, CFO
Cenkos Securities - Nominated Advisor and Broker
Giles Balleny/Max Gould (Corporate Finance)				Tel:  [phone]
Michael Johnson/Julian Morse (Sales)
Walbrook PR	Tel: [phone] or  [e-mail]
Anna Dunphy/Paul McManus			Mob: [phone] / Mob: [phone]

About Intelligent Ultrasound Group

Intelligent Ultrasound (AIM: IUG) is one of the world's leading 'classroom to clinic' ultrasound companies, specialising in real-time hi-fidelity virtual reality simulation for the ultrasound training market ('classroom') and artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market ('clinic'). Based in Cardiff in the UK and Atlanta in the US, the Group has two revenue streams:

Simulation

Real-time hi-fidelity ultrasound education and training through simulation.  Our main products are the ScanTrainer obstetrics and gynaecology training simulator, the HeartWorks echocardiography training simulator, the BodyWorks Eve Point of Care and Emergency Medicine training simulator with Covid-19 module and the new BabyWorks Neonate and Paediatric training simulator. To date over 1,350 simulators have been sold to over 650 medical institutions around the world.

Clinical AI software

Deep learning-based algorithms to make ultrasound machines smarter and more accessible using our proprietary ScanNav ultrasound image analysis technology. Current products on the market utilising this technology are GE Healthcare's SonoLyst software that is incorporated in their Voluson SWIFT ultrasound machine; ScanNav Anatomy PNB that simplifies ultrasound-guided needling by providing the user with real-time AI-based anatomy   highlighting for a range of medical procedures; and NeedleTrainer that teaches real-time ultrasound-guided needling and incorporates ScanNav Anatomy PNB.  

www.intelligentultrasound.com

NOTE: ScanNav Anatomy PNB is CE approved, but not yet available for sale in the US or any other territory requiring government approval for this type of product.

 

END

 

 

NOABKOBBBBKDDPB